BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17175031)

  • 1. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.
    Zhang-Gandhi CX; Drew PD
    J Neuroimmunol; 2007 Feb; 183(1-2):50-9. PubMed ID: 17175031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia.
    Xu J; Storer PD; Chavis JA; Racke MK; Drew PD
    J Neurosci Res; 2005 Aug; 81(3):403-11. PubMed ID: 15968640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes.
    Xu J; Chavis JA; Racke MK; Drew PD
    J Neuroimmunol; 2006 Jul; 176(1-2):95-105. PubMed ID: 16764943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.
    Liang Y; Lin S; Beyer TP; Zhang Y; Wu X; Bales KR; DeMattos RB; May PC; Li SD; Jiang XC; Eacho PI; Cao G; Paul SM
    J Neurochem; 2004 Feb; 88(3):623-34. PubMed ID: 14720212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effects of naturally occurring retinoid X receptor agonists isolated from Sophora tonkinensis Gagnep. via retinoid X receptor/liver X receptor heterodimers.
    Wang W; Nakashima KI; Hirai T; Inoue M
    J Nat Med; 2019 Mar; 73(2):419-430. PubMed ID: 30656541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.
    Xu J; Drew PD
    J Neuroimmunol; 2006 Feb; 171(1-2):135-44. PubMed ID: 16303184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
    Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
    Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis.
    Storer PD; Xu J; Chavis J; Drew PD
    J Neuroimmunol; 2005 Apr; 161(1-2):113-22. PubMed ID: 15748950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells.
    Wente W; Brenner MB; Zitzer H; Gromada J; Efanov AM
    Endocrinology; 2007 Apr; 148(4):1843-9. PubMed ID: 17194744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2.
    Secor McVoy JR; Oughli HA; Oh U
    J Neuroinflammation; 2015 Feb; 12():27. PubMed ID: 25889344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity.
    Xu J; Wagoner G; Douglas JC; Drew PD
    J Leukoc Biol; 2009 Aug; 86(2):401-9. PubMed ID: 19406833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver.
    Sabol SL; Brewer HB; Santamarina-Fojo S
    J Lipid Res; 2005 Oct; 46(10):2151-67. PubMed ID: 16024918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
    Liu QY; Quinet E; Nambi P
    Mol Cell Biochem; 2007 Aug; 302(1-2):203-13. PubMed ID: 17396233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages.
    Marathe C; Bradley MN; Hong C; Lopez F; Ruiz de Galarreta CM; Tontonoz P; Castrillo A
    J Biol Chem; 2006 Oct; 281(43):32197-206. PubMed ID: 16943198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with TO901317, a synthetic liver X receptor agonist, reduces brain damage and attenuates neuroinflammation in experimental intracerebral hemorrhage.
    Wu CH; Chen CC; Lai CY; Hung TH; Lin CC; Chao M; Chen SF
    J Neuroinflammation; 2016 Mar; 13(1):62. PubMed ID: 26968836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxysterols suppress inducible nitric oxide synthase expression in lipopolysaccharide-stimulated astrocytes through liver X receptor.
    Lee CS; Joe EH; Jou I
    Neuroreport; 2006 Feb; 17(2):183-7. PubMed ID: 16407768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists.
    Liang Y; Jiang XC; Liu R; Liang G; Beyer TP; Gao H; Ryan TP; Dan Li S; Eacho PI; Cao G
    Mol Endocrinol; 2004 Aug; 18(8):2000-10. PubMed ID: 15131258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.